Health Care

Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery

Perspective Therapeutics Touts Encouraging Updated Data From Gastrointestinal Cancer Trial, Stock Soars

Moderna Secures European Contract For Covid-19 Vaccine

Perspective Therapeutics Touts Encouraging Updated Data From Gastrointestinal Cancer Trial, Stock Soars

Moderna Secures European Contract For Covid-19 Vaccine

UnitedHealth Announces Replacement For Murdered Executive: Here's Who Will Lead Insurance Unit

Trump Administration Halts All Communications From The Centers For Disease Control As Bird Flu Spreads

UnitedHealth Announces Replacement For Murdered Executive: Here's Who Will Lead Insurance Unit

Trump Administration Halts All Communications From The Centers For Disease Control As Bird Flu Spreads

HCA Healthcare Q4 Earnings Beat Steet Estimates Despite Hurricane Impact, Announces $10 Billion Share Buyback Program

AstraZeneca To Pump $570 Million Into Canada, Driving Expansion, Job Growth

Health Care Recent News

Merck/Eisai's Keytruda Plus Lenvima Regime Shows Mixed Data In Esophagus Cancer Study

Merck and Eisai report mixed results from LEAP-015 trial of Keytruda and Lenvima in HER2-negative gastroesophageal cancer treatment.

Novo Nordisk's Weekly Amycretin Delivers Up to 22% Weight Loss in Study, Stock Soars

Novo Nordisk's amycretin trial results highlight significant weight loss in adults with obesity, with further clinical development planned.

Spotify Co-Founder Daniel Ek's Neko Health Secures $260 Million For US Expansion As It Compares Itself With 'The Apples Or Teslas Of The World'

Spotify co-founder Daniel Ek's health tech startup, Neko Health, raised $260 million to expand into the U.S., positioning itself alongside "Apples or Teslas" with its cutting-edge body scanning technology and a $1.7 billion valuation.

Intuitive Surgical Q4 Earnings: Revenue Beat, EPS Beat, Da Vinci Procedures Jump 18% And More

Intuitive Surgical reports financial results for the fourth quarter after the market close on Thursday. Here's a look at the key metrics from the quarter.

Moderna Shares Are Up Today: What's Going On?

Moderna shares closed up Thursday gaining momentum following recent comments by Oracle Chairman Larry Ellison about the role of artificial intelligence in revolutionizing cancer treatment.

Johnson & Johnson's MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: Analyst

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

FDA Warns Of Severe Allergic Reaction Risk With Teva's Multiple Sclerosis Drug

FDA issues new warnings about rare but severe allergic reactions, including anaphylaxis, linked to MS drug glatiramer acetate, urging immediate medical attention.

Why Is Abbott Stock Trading Higher On Thursday?

Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes Care and Medical Devices.

Wall Street Eyes Intuitive Surgical Q4 Earnings As Stock Hits New Heights

Intuitive Surgical's Q4 earnings report on Thursday expected to be $1.79 EPS and $2.25B revenue.

US Health Agency CMS To Appeal Medicare Star Ratings Recalculation Ruling

CMS appeals Medicare Star Rating ruling after a judge sided with UnitedHealth over unfair evaluations, impacting the 2025 plan assessments.

Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business

Dr. Reddy's Q3 FY2025 revenue reached $977 million, up 16%, with $165M net income. Growth fueled by NRT portfolio and global generics expansion.

Vigil Neuroscience's Alzheimer's Candidate Shows Encouraging Safety Profile, Plans To Start Mid-Stage Study In Q3

Vigil Neuroscience's VG-3927 Phase 1 trial shows strong safety, 50% sTREM2 reduction, and potential Alzheimer's treatment; Phase 2 begins Q3 2025.

RJK Jr.'s Involvement In Merck Lawsuit Faces Scrutiny Ahead Of Senate Hearing

Robert F. Kennedy Jr., HHS secretary nominee, faces criticism for financial ties to vaccine lawsuits, raising ethical concerns over regulatory impartiality.